The Ultimate Yeast Host Selection Matrix: S. cerevisiae vs. P. pastoris vs. Y. lipolytica
Humanized Glycosylation in Pichia pastoris: A Comprehensive Guide to Therapeutic Protein Excellence
Managing Metabolic Burden: A Guide to Balancing Growth and Production in Yeast
The Shift from In Vivo to In Vitro: Why Cell-Free Systems are Revolutionizing Protein Engineering
Cell-Free Protein Synthesis: A Faster Path to Toxic Protein Production
Genetics research is an important branch of biology. It determines organism's genetic features and genetic processes through genetic DNA, RNA, and so on. Genetics not only makes it possible to find out about the genetic origins and diversity of life, but affects almost every area of medicine, agriculture and ecology.
The importance and potential of genetic research
Sickle cell disease is common worldwide, primarily in Africa, the Mediterranean and the Middle East. A quarter of a million people worldwide are affected by the condition. The disease has a dramatic effect on patients' lives, including frequent medical treatment, low quality of life and diminished life expectancy.
Recombinant proteins are essential components of current biotechnology with applications across all fields of biotech – drug discovery, vaccine development, enzyme engineering, basic biology. But many natural proteins are folding wrong, forming inclusion bodies or unstable when they're expressed in host cells, and therefore have limited activity. So it is essential to choose the right expression system in order to optimise the expression efficiency and performance of recombinant proteins.If you're looking for comprehensive and efficient protein expression solutions, CD Biosynsis offers a top-tier Recombinant Protein Expression service.
The "cell tailors" in the biopharmaceutical workshop are rewriting the history of medicine. Walking into any modern biopharmaceutical company, you can see rows of giant bioreactors, where Chinese hamster ovary cells (CHO cells) are weaving life armor for humans to fight cancer and disease with precision to the nanoscale.
In the arena of biopharmaceutical research and development, recombinant protein technology is undergoing an unprecedented paradigm shift. Once upon a time, there was a saying in the laboratory: "He who gets the protein gets the world", but behind this saying lies the helplessness of many scientific researchers - they have to repeatedly try and make mistakes in the multiple mazes of gene synthesis, cell culture, and protein purification, like explorers holding an incomplete map. A study in a Nature sub-journal in 2018 revealed the scars of the industry: 43% of antibody drug projects worldwide are stuck in the preclinical stage due to insufficient expression, and 28% of candidate molecules fail in the third phase of clinical trials due to abnormal post-translational modifications. These cold numbers are like heavy hammers hitting the nerves of biopharmaceutical people.
In the global competition of biopharmaceutical R&D, the quality of protein expression and purification services has become the core variable that determines the progress of research and the transformation of results. The Nature Biotechnology 2023 industry analysis report pointed out that the annual R&D losses of global biopharmaceutical companies due to technical defects of outsourcing service providers are as high as 4.7 billion US dollars, of which 28.6% of preclinical research delays are directly attributed to technical parameter deviations in the expression and purification process. This data highlights the inevitability of service providers choosing to upgrade from simple technology procurement behavior to strategic decision-making. The current industry technology generation gap is significant: the leading companies have integrated CRISPR-Cas9 gene editing, AI-driven codon optimization algorithms and high-throughput screening platforms, while the tail 20% of suppliers still rely on traditional manual column chromatography processes, and their membrane protein functional activity recovery rate is only 53% of that of the leading companies.
In recombinant protein expression systems, codon optimization has become a key technical means to break through the bottleneck of heterologous gene expression. The biological basis of this strategy stems from the species-specific codon usage bias phenomenon - different organisms have formed unique codon usage frequencies through long-term evolution, and this frequency is significantly positively correlated with the abundance of tRNA pools in host cells. Taking the E. coli expression system as an example, the proportion of arginine codon AGA in its genome (21.3%) far exceeds the CGT codon preferred by mammalian cells (6.8%). This difference directly leads to the occurrence of up to 83% rare codon sites in unoptimized human genes in this system, causing a decrease in ribosome movement rate and accumulation of misfolded proteins.
In the past decade, the discovery of the CRISPR-Cas9 system has completely changed the research paradigm of genetic medicine. This technology, which originates from the bacterial immune mechanism, is like a precise molecular scalpel, bringing hope for the radical cure of single-gene genetic diseases and offering new avenues for treating a wide spectrum of genetic disorders.For more in - depth exploration of CRISPR - based gene - editing technologies, you can visit CRISPR - Based Gene - Editing Services. In the field of Duchenne muscular dystrophy (DMD) treatment, CRISPR-mediated exon reprogramming technology has achieved milestone progress - through the dual AAV vector delivery shear system, 38.2% of patients in the clinical trial (NCT05554276) detected functional dystrophin expression, and muscle biopsy showed a 52% reduction in muscle fiber necrosis area. In the treatment of cystic fibrosis (CF), the combination strategy of CRISPR-Cas12a and base editors successfully repaired the CFTR gene mutation in bronchial organoids, restoring chloride ion transport function to 49.3% of normal levels. This achievement was rated as one of the top ten medical breakthroughs in 2023 by Science magazine.
The CRISPR-Cas9 system is revolutionizing the field of agricultural biotechnology, and its single-base precision editing capability provides a molecular-level solution to food security challenges. The technology achieves trait improvements that are difficult to break through in traditional breeding through targeted genome editing: in the cassava starch synthesis pathway, editing of the GBSSI gene increased tuber yield by 25%; knocking out the rice SD1 gene created a dwarf strain that is resistant to lodging and can withstand a Category 10 typhoon. Field trial data confirm its application potential - wheat TaMLO double-allelic gene-edited lines are 89% resistant to powdery mildew, while soybean FAD2-1A/B site editing increases oleic acid content to 82%. Climate model predictions show that drought-tolerant lines constructed by editing the maize ZmNAC111 gene are expected to stabilize the yield level of 40% of the world's arid areas by 2040. A meta-analysis based on 85 authoritative studies between 2018 and 2023 showed that this technology can shorten the crop improvement cycle by 80%: rice blast-resistant varieties bred using prime editing technology can complete the transformation from laboratory to field in only 3.5 years, which has significant time advantages compared to the more than 15-year cycle required by traditional breeding methods.
In the context of the deep coupling of synthetic biology and gene editing technology, human reproductive genome intervention has broken through the threshold constraints of traditional medical ethics and entered a new stage of fierce competition between technical feasibility and ethical legitimacy. The global laboratory census data published in Nature Biotechnology in 2023 showed that the annual growth rate of experimental projects involving heritable gene modification reached 187%, of which 64% of the research targets were directed at non-disease-related phenotype regulation. This trend of technology application exposed the value orientation shift from basic research to application transformation. Taking the editing of the OCA2 gene (OMIM 611409) as an example, although the P protein encoded by this site has a strong correlation with eye pigment deposition (GWAS P=3.2×10^-28), its functional redundancy assessment has not yet reached a consensus in the academic community. The latest protein interaction network model (STRING v12.0) of the Center for Systems Biology at the University of Cambridge shows that OCA2 has 7 homologous substitution nodes in the melanin synthesis pathway, which fundamentally challenges the ethical defense basis of "gene necessity".
In the millennium-long game between humans and viruses, the emergence of CRISPR-Cas9 technology marks the first time that we have the ability to accurately rewrite the genome of pathogens. Since the engineering application of the CRISPR gene editing system in 2012, this technology derived from the bacterial immune mechanism has completely changed the paradigm of antiviral treatment. For more information on how CRISPR is being applied in gene editing, you can explore CRISPR - Based Gene - Editing Services.
In the wave of rapid development of synthetic biology, the global gene synthesis industry is undergoing unprecedented technological changes. As of 2024, the market size has reached 3.2 billion US dollars, and its growth engine comes from the innovative competition of the three giants GenScript, Integrated DNA Technologies (IDT) and Twist Bioscience. The former has pushed the accuracy of clinical-grade DNA synthesis to 99.999% with its revolutionary error correction algorithm, the middle one has reshaped the scientific research rhythm with 72-hour ultra-fast delivery, and the latter has achieved parallel production of 1.3 million oligonucleotides on a single chip with a silicon-based synthesis platform - this three-dimensional competition of "accuracy, speed, and scale" is rewriting the underlying rules of life science research.
Gene mutations cause systematic errors in protein synthesis by interfering with transcription initiation, splice site recognition, and translation fidelity. The ΔF508 mutation in the CFTR gene causes the loss of phenylalanine in the chloride channel domain, resulting in transmembrane transport dysfunction (cystic fibrosis) in 300,000 patients worldwide. This case confirms the common mechanism of more than 7,000 ClinVar pathogenic variants—80% of rare diseases originate from such molecular cascade disorders. Revealing the precise path from DNA mutation to protein functional defects is a prerequisite for developing CRISPR-mediated precision correction strategies.
When the second hand of the clock ticks once, more than 18 families in the world receive cancer diagnosis notices, and 9 lives are being devoured by the disease. The 2023 monitoring map of the International Agency for Research on Cancer (IARC) reveals that the number of new cancer cases worldwide has exceeded 20.3 million, and the number of deaths is approaching 10 million. This sword of Damocles hanging over the heads of mankind is showing a sharper blade with a growth rate of 15% every decade - the incidence rate may surge by 50% in 2040, and behind this number is the critical point of collapse that countless medical systems are about to face.
Modern biotechnology relies heavily on recombinant protein production because it allows scientists to produce proteins for therapeutic uses as well as industrial and research purposes. Among the various expression systems available the yeast expression system demonstrates exceptional strength and adaptability. Yeast platforms excel in protein production by combining the straightforward nature of prokaryotic systems with eukaryotic capabilities for post-translational modifications. The technology offers useful features along with its distinct set of difficulties. The article thoroughly examines the yeast expression system and assesses its strengths and weaknesses before presenting optimal methods to enhance recombinant protein production.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
CRISPR-Cas9 technology evolved from bacterial defense mechanisms into a revolutionary gene editing tool.
1.1 Overview of the A549 Lung Cancer Cell Line
.cfps-res { --ink: #1a1a1a; --heading: #222222; --subhead: #333333; --text: #444444; --muted: #666666; --line: #e5e5e5; --soft: #f7f7f7; --green: #2e7d32; --green-dark: #1b5e20; --green-soft: #e8f5e9; --green-border: #c8e6c9; --warn: #f9a825; font-family: Georgia, "Times New Roman", "Segoe UI", serif; color: var(--text); line-height: 1.7; max-width: 860px; margin: 0 auto; } .cfps-res *, .cfps-res *::before, .cfps-res *::after { box-sizing: border-box; } .cfps-res h2 { color: var(--heading); border-bottom: 2px solid var(--line); padding-bottom: 5px; margin-top: 40px; font-size: 1.35rem; } .cfps-res h2:first-of-type { margin-top: 8px; } .cfps-res h3 { color: var(--subhead); margin-top: 24px; font-size: 1.1rem; } .cfps-res h4 { color: #444; margin-top: 16px; font-size: 1rem; } .cfps-res p { margin-bottom: 15px; text-align: justify; } .cfps-res ul, .cfps-res ol { margin: 0 0 16px 25px; padding: 0; } .cfps-res ul { list-style-type: disc; } .cfps-res ol { list-style-type: decimal; } .cfps-res li { margin-bottom: 8px; } .cfps-res a { color: var(--green); text-decoration: underline; text-underline-offset: 2px; } .cfps-res a:hover { color: var(--green-dark); } .cfps-res a::before, .cfps-res a::after, .cfps-res .chip::before, .cfps-res .chip::after, .cfps-res .cta-btn::before, .cfps-res .cta-btn::after, .cfps-res .related a::before, .cfps-res .related a::after, .cfps-res .ref-item a::before, .cfps-res .ref-item a::after { content: none !important; display: none !important; width: 0 !important; height: 0 !important; margin: 0 !important; padding: 0 !important; border: none !important; background: none !important; box-shadow: none !important; } .cfps-res a:not(.cta-btn):not(.chip) { background-image: none !important; } .cfps-res table { width: 100%; border-collapse: collapse; margin: 25px 0; font-size: 0.9em; } .cfps-res th, .cfps-res td { border: 1px solid var(--line); padding: 12px; text-align: left; vertical-align: top; } .cfps-res th { background-color: var(--soft); font-weight: bold; color: var(--heading); } .cfps-res .paradox { background-color: #fff8e1; border-left: 5px solid var(--warn); padding: 15px; margin: 20px 0; } .cfps-res .paradox p:last-child { margin-bottom: 0; } .cfps-res .callout { background: var(--soft); border: 1px solid var(--line); border-left: 4px solid var(--green); padding: 14px 16px; margin: 20px 0; } .cfps-res .callout p:last-child { margin-bottom: 0; } .cfps-res .takeaways { background: var(--green-soft); border: 1px solid var(--green-border); border-left: 4px solid var(--green); padding: 16px 18px; margin: 0 0 28px; border-radius: 0 8px 8px 0; } .cfps-res .takeaways h3 { margin: 0 0 10px; color: var(--green-dark); font-size: 0.95rem; text-transform: uppercase; letter-spacing: 0.04em; } .cfps-res .takeaways ul { margin-bottom: 0; } .cfps-res .faq-item { margin: 0 0 14px; padding: 14px 16px; border: 1px solid var(--line); border-radius: 8px; background: #fff; } .cfps-res .faq-item h3 { margin: 0 0 8px; color: var(--heading); font-size: 1.02rem; } .cfps-res .faq-item p { margin: 0; text-align: left; font-size: 0.95rem; } /* Related Services — soft gray, forced line break */ .cfps-res .related { margin: 32px 0 8px !important; padding: 22px !important; background: #fafafa !important; border: 1px solid #eeeeee !important; border-left: 4px solid var(--green) !important; border-radius: 8px !important; overflow: hidden; } .cfps-res .related-title { display: block !important; width: 100% !important; margin: 0 0 8px !important; padding: 0 !important; color: var(--heading) !important; font-size: 1.15rem !important; font-weight: 700 !important; line-height: 1.35 !important; font-family: "Segoe UI", system-ui, sans-serif !important; } .cfps-res .related-desc { display: block !important; width: 100% !important; clear: both !important; margin: 0 0 16px !important; padding: 0 !important; color: var(--muted) !important; font-size: 0.95rem !important; line-height: 1.55 !important; text-align: left !important; } .cfps-res .chip-row { display: grid !important; grid-template-columns: repeat(3, minmax(0, 1fr)) !important; gap: 10px !important; margin: 0 !important; padding: 0 !important; list-style: none !important; width: 100% !important; } .cfps-res .chip-row > .chip { display: flex !important; align-items: center !important; justify-content: center !important; box-sizing: border-box !important; width: 100% !important; min-height: 48px !important; margin: 0 !important; padding: 10px 12px !important; background: #fff !important; border: 1px solid #e0e0e0 !important; border-radius: 6px !important; font-size: 0.82rem !important; font-family: "Segoe UI", system-ui, sans-serif !important; font-weight: 600 !important; color: var(--green-dark) !important; text-decoration: none !important; text-align: center !important; line-height: 1.35 !important; white-space: normal !important; word-break: break-word !important; float: none !important; } .cfps-res .chip-row > .chip:hover { border-color: var(--green) !important; color: var(--green) !important; background: var(--green-soft) !important; } /* CTA — light green panel, solid green button */ .cfps-res .cta-box { margin: 36px 0 8px !important; padding: 28px !important; background: var(--green-soft) !important; color: var(--ink) !important; border-radius: 10px !important; border: 1px solid var(--green-border) !important; text-align: left !important; } .cfps-res .cta-box .cta-title { display: block !important; color: var(--heading) !important; margin: 0 0 10px !important; font-size: 1.25rem !important; font-weight: 700 !important; line-height: 1.3 !important; font-family: "Segoe UI", system-ui, sans-serif !important; } .cfps-res .cta-box p { color: var(--text) !important; margin: 0 0 20px !important; text-align: left !important; font-size: 0.95rem !important; max-width: 640px; } .cfps-res a.cta-btn { display: inline-flex !important; align-items: center !important; justify-content: center !important; min-width: 220px !important; min-height: 48px !important; padding: 14px 28px !important; margin: 0 !important; background: var(--green) !important; color: #ffffff !important; border: none !important; border-radius: 8px !important; font-family: "Segoe UI", system-ui, sans-serif !important; font-size: 0.95rem !important; font-weight: 700 !important; line-height: 1.2 !important; text-decoration: none !important; text-align: center !important; box-shadow: none !important; float: none !important; } .cfps-res a.cta-btn:hover { background: var(--green-dark) !important; color: #ffffff !important; } @media (max-width: 720px) { .cfps-res .chip-row { grid-template-columns: repeat(2, minmax(0, 1fr)) !important; } } @media (max-width: 480px) { .cfps-res .chip-row { grid-template-columns: 1fr !important; } .cfps-res a.cta-btn { width: 100% !important; min-width: 0 !important; } } .cfps-res .ref-section { margin-top: 36px; padding-top: 20px; border-top: 1px solid var(--line); } .cfps-res .ref-section h2 { margin-top: 0; } .cfps-res .ref-list { margin: 0; padding: 0; } .cfps-res .ref-item { margin: 0 0 14px; padding: 0; font-size: 0.9rem; color: var(--muted); text-align: left; line-height: 1.65; } .cfps-res .ref-item a { color: var(--green); font-weight: 600; text-decoration: none; font-family: "Segoe UI", system-ui, sans-serif; font-size: 0.88rem; } .cfps-res .ref-item a:hover { text-decoration: underline; }
The rise of Cell-Free Protein Synthesis (CFPS) has dramatically accelerated the pace of protein discovery, offering the speed (IDT model) and scale (Twist model) necessary for High-Throughput Cell-Free Protein Expression and Screening. However, achieving high expression yield does not automatically guarantee high functional yield. This divergence—the Folding Paradox—is the central challenge in CFPS, especially when synthesizing complex eukaryotic proteins such as antibodies or membrane receptors.
In the global race for biotherapeutics and vaccine development, speed is the ultimate competitive advantage. Just as the three major forces in gene synthesis—the High-Fidelity Leader (Accuracy), the High-Speed Platform (Speed), and the Industrial Scale Producer (Scale)—redefined genetic engineering, Cell-Free Protein Synthesis (CFPS) is now operating as the decisive acceleration engine in the discovery pipeline. It offers the capacity to generate functional proteins, antigens, and antibodies in days rather than weeks, critically shortening the drug development cycle by up to 40%.
The core promise of Cell-Free Protein Synthesis (CFPS) is speed and modularity, making it an indispensable tool for rapid prototyping and high-throughput screening (HT-CFPS). However, scaling CFPS from micro-reactions to industrial volumes (liter scale) presents a significant economic hurdle. While a High-Speed Platform excels at rapid validation, its reagent cost per gram of protein often dwarfs that of traditional fermentation.
In structural biology and drug discovery, two classes of proteins—toxic proteins (e.g., bacterial toxins, certain pro-apoptotic factors) and membrane proteins (e.g., GPCRs, ion channels)—represent the greatest bottlenecks. Traditional in vivo expression methods, whether in microbial or mammalian cells, frequently fail. Toxic proteins kill the host cell, and membrane proteins misfold or aggregate in the absence of a stabilizing lipid environment.
Choosing between high-yield E. coli lysates and high-fidelity mammalian systems is now the central decision in cell-free protein synthesis (CFPS). This guide compares platforms by speed, cost, and functional output—so you can match the lysate to your protein class before the first reaction runs.
CRISPR genome editing has become the default route for building knock-out cell lines and for installing defined sequences.
Corynebacterium glutamicum is the industrial workhorse behind a large share of global amino acid and organic acid production, and deleting genes is the most direct way to redirect its metabolism. This guide explains how gene knockout actually works in C. glutamicum — homologous recombination, CRISPR-assisted editing, and counter-selection strategies — and how those mechanisms translate into a practical deletion strain engineering workflow.
Gene editing in stem cells represents a cutting-edge service in the realm of molecular biology, offering unparalleled precision and potential in genetic research and therapy. This sophisticated technique involves the intentional alteration of genetic material within stem cells, enabling researchers to investigate gene functions, model complex diseases, and pioneer potential therapeutic interventions. The significance of this service cannot be overstated, as it provides invaluable insights into the genetic underpinnings of various conditions and opens new avenues for innovative treatments.
DNA assembly and cloning are critical techniques in synthetic biology that enable researchers to create and modify DNA sequences for various applications, including gene editing, protein engineering, and synthetic biology. Traditional cloning methods, such as restriction enzyme digestion and ligation, can be time-consuming and often result in unwanted mutations or errors. However, recent advancements in DNA assembly and cloning techniques have enabled researchers to construct complex DNA sequences with greater speed, accuracy, and efficiency.
Genetic circuits are complex systems of interacting genes that can be designed to perform specific functions, such as producing valuable chemicals or sensing environmental signals. The field of synthetic biology has enabled the creation of increasingly sophisticated genetic circuits, which has great potential for various industries. CD Biosynsis provides a wide range of services for genetic circuits design in this field.
In recent years, the field of synthetic biology has made significant advancements in developing new genetic systems that allow for precise and efficient control of gene expression and editing. One promising approach is the use of orthogonal genetic systems, which enable the simultaneous regulation and editing of multiple genes with high specificity and efficiency. CD Biosynsis is leading the way in providing cutting-edge services in this exciting orthogonal genetic systems field.
In the field of synthetic biology, genetically modified organisms (GMOs) have been engineered to produce a variety of products at an industrial scale. However, concerns have been raised surrounding the ecological risks associated with the release of GMOs outside of controlled environments. Biocontainment systems are needed to neutralize these GMOs and prevent them from causing harm to the environment. In addition, alternative selection markers are needed to replace costly and risky antibiotics.
Cell-free systems are gaining popularity as a platform for protein synthesis due to their rapid and efficient nature. These systems are free from cell walls and membranes and can be used to synthesize proteins directly from DNA templates. They offer several advantages over traditional methods of protein expression, including increased speed, simplicity, and cost-effectiveness. Synthetic biology has played a significant role in advancing cell-free systems by providing new methods for DNA synthesis and assembly, as well as new enzymes and substrates for protein synthesis.
Whole-cell biosynthesis is a rapidly growing field in synthetic biology that involves the use of living cells as a platform for the production of valuable compounds. This approach offers a number of advantages over traditional chemical synthesis, including improved efficiency, reduced waste, and the ability to use renewable resources. CD Biosynsis is a leading company in the field of whole-cell biosynthesis, providing a range of services for the production of a wide variety of compounds using genetically modified microorganisms.
Spore engineering is a cutting-edge technology that has revolutionized the field of synthetic biology. It involves the genetic modification of bacterial spores, which are highly resistant structures that can survive harsh environmental conditions. Spore engineering has various applications in the fields of bioremediation, bioproduction, drug delivery, and biosensing. CD Biosynsis is a leading company in spore engineering, providing innovative solutions to meet the needs of our clients.
The use of antibiotic resistance genes as selection markers in synthetic biology strains has been a common practice for many years. However, the increasing concern over the spread of antibiotic resistance has prompted scientists to develop alternative selection systems. The use of antibiotic-free selection systems is not only a safer option but also more cost-effective in the long run.
Synthetic biology has emerged as a promising approach for engineering microorganisms to perform complex metabolic tasks, including biodegradation. Biodegradation pathway engineering involves the modification of microbial metabolism to degrade specific contaminants or pollutants. At CD Biosynsis, we offer a range of services for biodegradation pathway engineering, utilizing the latest synthetic biology tools and techniques to design and optimize microbial consortia for biodegradation applications.
De novo protein design is revolutionizing synthetic biology by enabling the creation of tailor-made proteins with unprecedented functions. Our services empower industries and researchers to harness the potential of these engineered biomolecules for diverse applications, from therapeutics to materials science.
Our high-throughput screening services are dedicated to assisting researchers and organizations in achieving their scientific goals efficiently and effectively, leveraging state-of-the-art technology and expertise to accelerate progress in diverse fields of study.
CD Biosynsis is committed to providing high-quality services to our clients. Our specialized synthetic biology platform specializes in providing tools, libraries of gene parts for metabolic pathways, and bioengineering for chemical production, as well as designing and optimizing metabolic pathways for maximum efficiency.
Genetic circuits are complex systems of interacting genes that can be designed to perform specific functions, such as producing valuable chemicals or sensing environmental signals. The field of synthetic biology has enabled the creation of increasingly sophisticated genetic circuits, which has great potential for various industries. CD Biosynsis provides a wide range of services for genetic circuits design in this field.
Bacterial strain modification is a powerful tool in synthetic biology, allowing for the manipulation of bacterial characteristics to improve their efficiency in various applications.
Automation screening is a pivotal technology in synthetic biology, revolutionizing research across various domains. By harnessing the power of automation, CD Biosynsis' services contribute to the advancement of life sciences, enabling rapid, systematic, and high-throughput analysis that was previously unattainable through manual methods.
CD Biosynsis has expertise in pathway engineering, computational tools, and collaborative approaches that are well suited to meet the diverse needs of our clients in synthetic biotechnology.
Oligo Synthesis is the process of creating short sequences of nucleic acids, known as oligonucleotides. These oligonucleotides are widely used in various research applications, such as PCR, gene synthesis, and DNA sequencing. They play a crucial role in molecular biology and biotechnology.
Custom DNA oligos are short, single-stranded DNA sequences that are synthesized to order. They play a crucial role in various fields of molecular biology research, genetic testing, and biotechnology applications. These oligos are designed with specific sequences to meet the unique requirements of researchers and scientists.
Primers (Oligonucleotides) are the essential, short synthetic DNA molecules that initiate enzymatic reactions such as PCR, sequencing, reverse transcription, and gene assembly. The success of almost every molecular biology and synthetic biology experiment hinges on the quality, purity, and thoughtful design of these starting materials. Faulty primers lead to non-specific amplification, poor efficiency, and inaccurate results, requiring costly re-optimization.
Precision-manufactured fluorescent oligonucleotide probes for molecular diagnostics, qPCR, and genomic detection applications. Our proprietary synthesis platform delivers exceptional coupling efficiency with comprehensive quality verification for clinical and research applications.
NGS Oligos, encompassing specialized adapters, primers, and index sequences, are the foundational chemical components required for preparing samples for all major Next-Generation Sequencing (NGS) platforms (Illumina, Ion Torrent, PacBio, Oxford Nanopore). The success of complex NGS applications, such as Single-Cell Sequencing, ChIP-Seq, and Ultra-Deep Sequencing, critically depends on the quality and purity of these synthetic oligonucleotides.
Custom Modified Oligonucleotides are synthetic nucleic acids that incorporate non-natural chemical groups, fluorescent dyes, quenchers, linkers, or backbone stabilizing modifications. These specialized molecules are vital tools in cutting-edge research, serving as advanced molecular probes, therapeutic agents (e.g., antisense), aptamers, and components of sophisticated nanotechnology and biosensors. The successful synthesis of these complex molecules requires specialized chemistry and rigorous purification protocols.
Accelerate your ASO research and development with our custom antisense oligonucleotide synthesis services. From routine gapmers to complex PMO and LNA-modified sequences, we deliver high-purity therapeutic-grade ASOs with comprehensive quality control to meet your discovery and preclinical needs.
Accelerate your TLR9 immunotherapy research with custom CpG oligodeoxynucleotides consistently manufactured to your exact specifications. From standard Class A/B/C sequences to complex modified constructs, we deliver high-purity immunostimulatory oligonucleotides with comprehensive quality verification.
Custom Oligo Libraries are collections of custom-designed oligonucleotides that are synthesized for various applications in molecular biology research. These libraries consist of a set of specific DNA or RNA sequences that can be used for tasks such as gene expression analysis, mutation detection, and target enrichment.
Oligo Pool Synthesis is a cutting-edge technique used in molecular biology to simultaneously synthesize a large number of DNA or RNA sequences. It offers researchers the ability to generate complex pools of oligonucleotides that can be utilized in a wide range of applications, including next-generation sequencing, gene synthesis, and targeted mutagenesis. By synthesizing multiple sequences in parallel, Oligo Pool Synthesis streamlines the experimental process and saves valuable time and resources.
Accelerate your research with CRISPR-Cas9 mediated gene knockout cell lines manufactured to your exact specifications. From single-gene knockouts to complex multiplexed editing, we deliver validated, sequence-verified knockout models with industry-leading efficiency.
Site-directed mutagenesis is a very useful in vitro technique to create specific, targeted mutations in a known DNA sequence. It can efficiently change the characterization of target proteins. Site-directed mutagenesis can be used as a precision tool to enable synthetic biology. It plays an essential role in a variety of synthetic biology research, such as the study of gene regulatory elements, protein structure and functions, enzyme active sites and novel proteins.
Yeast strain modification is a process of altering the genetic material of yeast cells to introduce new traits or improve existing ones. This process has been widely used in various industries such as food and beverage, pharmaceuticals, and biofuels. Yeast strain modification involves the use of genetic engineering techniques to introduce genes or delete genes that control specific traits, such as fermentation rate, sugar metabolism, or stress resistance.
Glycosylation is a critical post-translational modification that affects the stability, activity, and immunogenicity of therapeutic proteins. P. pastoris is a well-characterized yeast expression system that can produce high levels of recombinant proteins with human-like glycosylation patterns. Glycoengineering of P. pastoris involves modifying the yeast's glycosylation pathways to produce recombinant proteins with specific glycan structures that match those found in humans. The resulting glycoengineered P. pastoris strains can produce recombinant proteins with improved efficacy, stability, and safety profiles.
Saccharomyces cerevisiae genetic engineering services provide advanced solutions for manipulating the genome of this widely used yeast species, enabling researchers to study gene function, optimize metabolic pathways, and produce valuable bioproducts. Our comprehensive services offer support from initial project design to final validation, ensuring precise and reliable genetic modifications tailored to your specific research and biotechnological needs.
Yeast Cell Surface Engineering stands at the forefront of biotechnological innovations, involving a sophisticated process of modifying the surface of yeast cells to enhance their functionality. This process could involve the introduction of new proteins to the yeast cell surface or modification of existing ones. These changes can fundamentally alter the cell's interaction with its environment, leading to an increase in its industrial utility. Yeast Cell Surface Engineering relies on cutting-edge technology and thorough scientific research to transform yeast cells into more versatile and useful organisms.
Our Yeast Engineering Service involves the modification and optimization of yeast strains for various applications. We utilize advanced genetic and genomic tools to engineer yeast strains that are tailored to your specific needs. This service includes, but is not limited to, strain construction, transformation, and fermentation optimization. Our expert team works diligently to ensure that the engineered yeast strains exhibit the desired traits, thereby maximizing their utility in your applications.
In silico screening is revolutionizing synthetic biology by offering a powerful and cost-effective approach to biological research and drug discovery. Our comprehensive services, coupled with cutting-edge technology and expert guidance, position us at the forefront of this transformative field. Unlock the full potential of your research with our In Silico Screening Services.
Genetic Engineering is the manipulation of an organism's genetic material to introduce desired characteristics or traits. It involves altering the DNA sequence of an organism to achieve specific outcomes, such as increased crop yield or improved disease resistance.
CD Biosynsis provides high-quality synthetic DNA library construction services for synthetic biology researchers around the world to facilitate their cutting-edge research. Our strong expertise coupled with advanced techniques can help bring diverse synthetic applications and creative ideas to fruition.
CD Biosynsis has a team of experienced and highly skilled scientists to provide synthetic biology researchers around the world with high-quality cell-based protein expression services to facilitate their cutting-edge research.
Metabolic engineering and synthetic biology have combined to become one of the most promising fields. CD Biosynsis provides a comprehensive portfolio of metabolic services for the build phase of the Design-Build-Test-Learn (DBTL) cycle to help synthetic biology researchers around the world facilitate their cutting-edge research. We provide powerful tools and tailored solutions to help our customers overcome the challenges in synthetic biology and bring diverse creative ideas to fruition.
CD Biosynsis provides comprehensive services for plant metabolic engineering to facilitate the cutting-edge research of synthetic biology researchers around the world.
Through DNA assembly and cloning services, CD Biosynsis aims to provide researchers and innovators with streamlined access to complex genetic constructs, which will alleviate the technological challenges associated with DNA manipulation and enable researchers to focus on their core objectives, facilitating their breakthroughs in different fields.
CD Biosynsis provides a comprehensive suite of tools to accelerate your synthetic biology research. By harnessing the power of high-throughput screening and in-depth characterization, we empower researchers and innovators to unlock the full potential of biological systems for a wide range of applications, from drug discovery to biotechnology advancements.
CD Biosynsis provides professional backbone building services for synthetic biology researchers around the world to facilitate their cutting-edge research. Our aim is to obtain protein backbone configurations that satisfy a set of predefined requirements by the customers.
Metabolic Engineering and Pathway Design is a specialized offering provided by our company. It involves the modification of metabolic pathways in microorganisms, particularly E. coli, to optimize the production of desired chemicals. Through targeted genetic modifications, we can enhance the metabolic capabilities of these organisms, enabling them to efficiently synthesize valuable chemicals. Our team of experts utilizes state-of-the-art techniques and tools to design and engineer metabolic pathways that are tailored to meet your specific requirements.
CD Biosynsis provides professional enzyme engineering services to facilitate the cutting-edge research of synthetic biology researchers around the world.
Plant strain modification, also known as plant breeding or genetic engineering, involves the deliberate alteration of a plant's genetic makeup to achieve specific desired traits. This process aims to improve crop yield, quality, resistance to pests and diseases, and tolerance to various environmental conditions. Plant strain modification is a powerful tool in plant biotechnology that enables the manipulation of plant traits to improve crop yields, enhance disease resistance, and increase nutritional value.
Plant metabolic pathway engineering is a powerful tool that has revolutionized the field of synthetic biology. It involves the modification of plant metabolic pathways using genetic engineering techniques to produce high-value compounds, such as pharmaceuticals, industrial chemicals, and biofuels. The use of synthetic biology tools in plant metabolic engineering has enabled the production of these valuable compounds in a cost-effective and sustainable manner.
Plant virus-based vector systems have emerged as an efficient and practical tool for the production of recombinant proteins in plants. This technology has revolutionized the field of synthetic biology and has been widely adopted for the production of high-value proteins, such as vaccines, antibodies, and enzymes.
Plant molecular farming is a rapidly growing field in synthetic biology that utilizes plants as bioreactors for the production of recombinant proteins. This innovative approach presents many advantages over traditional mammalian-based expression systems, such as lower costs, reduced risk of contamination, and increased scalability. At CD Biosynsis, we specialize in providing high-quality services for plant molecular farming, leveraging our expertise in synthetic biology and plant biotechnology to offer customized solutions for our clients.
CD Biosynsis has been at the forefront of strain engineering research and development for years. The team of experts has dedicated to understanding the complex interactions between microorganisms and their environments, and have developed innovative strategies to optimize their performance in various applications.
Strain Development Services involve the modification, optimization, and customization of microorganisms, cells, or other biological entities for specific applications. This field plays a crucial role in various industries, including biotechnology, pharmaceuticals, agriculture, and environmental science. The goal is to engineer or develop strains with desired characteristics, such as increased productivity, enhanced functionality, improved resistance to environmental factors, or the expression of specific traits.
CD Biosynsis provides comprehensive protein characterization services for synthetic biology researchers around the world to facilitate their cutting-edge research.
Genetic engineering has revolutionized various industries, including healthcare, agriculture, and biomanufacturing. The field of synthetic biology, which involves the design and construction of new biological systems or redesigning existing ones, has further expanded the possibilities of genetic engineering. Genetic engineering has been a rapidly evolving field over the past few decades, with the development of new technologies and techniques that have made it possible to manipulate genes with unprecedented precision and efficiency. The potential of genetic engineering to revolutionize various industries has been well-established, but it also raises ethical and regulatory challenges that need to be addressed.
Synthetic biology is a rapidly growing field that has revolutionized the way we think about the production of biological compounds. One of the key challenges in synthetic biology is the optimization of metabolic pathways in strains to produce high-value compounds. Metabolic pathway optimization involves the design, engineering, and optimization of the enzymatic and regulatory processes that control the production of specific compounds in microbial cells. However, the complexity of cellular metabolism and the limited understanding of the underlying mechanisms make the optimization of metabolic pathways a tedious and time-consuming process. Therefore, new approaches are required to accelerate the pathway optimization process and improve the efficiency and accuracy of the metabolic engineering process.
Plasmids are small, self-replicating circular DNA molecules that play a crucial role in synthetic biology. They are used to introduce genes of interest into host cells, allowing for the manipulation and engineering of biological systems.
Gene circuit design services provide an innovative approach to synthetic biology, enabling the creation of custom genetic circuits that can regulate cellular behavior, control gene expression, and perform complex biological functions. These services offer comprehensive solutions for designing, constructing, and validating gene circuits tailored to your specific research or biotechnological needs. By leveraging advanced tools and expertise in genetic engineering, we help you develop sophisticated gene circuits that can revolutionize research and therapeutic applications.
Protein Analysis Services refers to a series of experimental technologies and services used to characterize proteins. These services cover everything from the detection, purification, and identification of proteins to detailed analysis of their structure and function. These services are widely used in fields such as biomedical research, drug development and industrial production.
In the rapidly advancing field of synthetic biology, the performance evaluation of strains plays a pivotal role in optimizing biological systems for various applications. Synthetic biology combines principles from biology, engineering, and computer science to design and construct new biological parts, devices, and systems with enhanced functionalities.
Fermentation is a fundamental biological process that has been used for centuries to produce a wide range of products, including food, beverages, pharmaceuticals, and biofuels. Traditional methods of fermentation monitoring involve time-consuming and costly methods such as manual sampling and offline analysis. However, monitoring the fermentation process in real-time can be challenging due to the complex interactions between microorganisms, substrates, and environmental factors.
CD Biosynsis provides custom genome reprogramming services for synthetic biology researchers around the world to facilitate their cutting-edge research. Our strong expertise coupled with advanced techniques can help bring diverse synthetic applications and creative ideas to fruition.
Synthetic biology involves engineering biological systems through the design and construction of new biological parts, devices, and systems, or the modification of existing ones. One of the key challenges in synthetic biology is to create efficient and reliable metabolic pathways in microbial strains.
In a world where scientific breakthroughs hinge on innovative tools, our novel CRISPR system stands at the forefront of genetic engineering innovation. With its precision, versatility, and diverse applications, it empowers researchers and industry leaders to push the boundaries of what's possible in the realm of synthetic biology.
Protein sequence design and optimization is a scientific process of creating or modifying protein sequences to achieve desired functional properties or enhance protein stability. It involves utilizing computational algorithms and experimental techniques to design novel protein sequences with specific structural and functional characteristics.
CD Biosynsis's synthetic biology platform is dedicated to providing high-quality protein library design services to help biologists around the world design protein variant collections to support innovation in a variety of fields.
Strain improvement is a critical aspect of synthetic biology that involves the targeted enhancement of microorganisms or cell lines for specific applications. It revolves around modifying the genetic, metabolic, and physiological characteristics of these organisms to optimize their performance in various industrial, medical, or research contexts.
Phenotypic screening and selection is a crucial step in the development of novel strains with improved performance in synthetic biology. With the increasing demand for high-value products and sustainable solutions, there is a growing need for efficient and effective screening methods that can identify the most promising strains for further development. At CD Biosynsis, we offer a range of services for phenotypic screening and selection, utilizing cutting-edge technologies and expertise in synthetic biology to deliver the best possible results for our clients.
Microbial strains play a significant role in the production of various industrial compounds, such as biofuels, chemicals, and pharmaceuticals. However, the performance of these strains is often limited by their natural diversity, making it challenging to achieve high production yields and efficiency. To overcome these limitations, researchers have turned to synthetic biology and strain domestication as promising strategies for improving microbial strains.
Adaptive evolution is a powerful tool used in synthetic biology to improve the performance of microbial strains for various biotechnological applications. The technique involves the selection and propagation of genetic variants with desirable traits over multiple generations, resulting in the evolution of the microbial population towards a specific objective. One of the significant advantages of adaptive evolution is that it can be used to modify a strain's genome without the need for genetic engineering. This approach allows for the optimization of a strain's performance by selecting for natural genetic variation that confers a selective advantage under specific growth conditions.
Mutagenesis is a powerful tool that enables researchers to generate genetic diversity in microorganisms and other organisms. It involves the induction of mutations in the genome of an organism, which can result in the generation of novel phenotypes that may have beneficial properties for various applications, including industrial biotechnology. Synthetic biology has been instrumental in the development of novel methods for mutagenesis that enable the generation of large libraries of mutants with diverse phenotypes.
One of the key components of synthetic biology is the creation of novel strains with unique properties that can be used for various applications such as biotechnology, medicine, and agriculture. Strain hybridization is an essential technique in synthetic biology that involves the combination of genetic material from different strains to create a new hybrid strain with desired traits.
Synthetic biology is a rapidly growing field that has the potential to revolutionize many industries, including biotechnology, medicine, and agriculture. One of the key tools in synthetic biology is gene editing, which allows scientists to manipulate the DNA of organisms to create new functions, optimize metabolic pathways, and engineer new traits. In recent years, the development of new gene editing tools, such as CRISPR-Cas9, has made gene editing faster, cheaper, and more precise than ever before.
PCR Cloning is a powerful molecular biology technique that allows scientists to amplify a specific DNA sequence and insert it into a vector for further study or manipulation. This method has revolutionized the field of genetic engineering by enabling the creation of multiple copies of DNA fragments, which can be used for various applications in molecular biology and biotechnology.
Single-cell gene editing represents a pinnacle of precision and specificity in molecular biology, offering an unparalleled approach to genetic research and therapeutic development. This advanced service involves the modification of genetic material within individual cells, allowing researchers to dissect gene function with exceptional accuracy, model intricate disease mechanisms, and develop tailored therapeutic strategies. The importance of this service is profound, as it provides critical insights into cellular heterogeneity and genetic variability, paving the way for innovative treatments and personalized medicine.
Protein Purification Service is an important service in the field of biotechnology. It aims to extract and purify high-purity, biologically active proteins from organisms or protein-containing solutions through a series of complex experimental steps. This process usually includes multiple stages such as rough separation, preliminary purification and fine purification, using various technical means such as extraction, precipitation, centrifugation, chromatography, etc. to remove impurities while maintaining the biological activity of the protein.
Our company is a professional CRO service outsourcing company committed to providing customers with high-quality customized protein purification services. Our E. The coli protein purification service provides His-tag or GST-tag options from gene synthesis to labeled protein purification, with purities of 85%, 90% or 95%, and quantities ranging from milligrams to grams.
Custom Membrane Protein Purification is a highly specialized service designed to provide customers with customized membrane protein purification solutions. Such services often involve the use of advanced technology platforms and multiple chromatography methods to achieve efficient expression and purification of target membrane proteins.
Mammalian cell protein purification is a process to extract and purify protein from mammalian cells.It's often involved in several steps to guarantee a protein is highly pure and retain its biological activity.
CD biosynsis is a professional CRO enterprising who provides large-scale protein purification service. In biotechnology and pharma companies, the protein purification process is an important development step of product safety and quality. We provide the solution of lab to commercial protein purification, applying to the various step of protein purification, from initial expression-isolation to final purification.
Base editing is an innovative and groundbreaking technology that allows for precise modifications to be made in the DNA of living organisms. It provides a unique approach to genetic engineering by enabling the direct conversion of one DNA base pair to another, without the need for introducing foreign genetic material. This targeted approach holds tremendous potential for a wide range of applications, including the treatment of genetic diseases, the enhancement of crop yields, and the advancement of scientific research.
Animals Genetic Engineering is a cutting-edge service that leverages advanced technologies to enhance the genetic traits of animals. Through precise genetic modifications, we aim to improve various aspects of animal health, productivity, and sustainability. Our team of experienced genetic engineers is dedicated to delivering customized solutions that meet the specific needs of our clients, while adhering to ethical guidelines and ensuring the welfare of the animals involved.
Genetic engineering plays a crucial role in enhancing plant traits and has significant importance in modern agriculture. By modifying plant genes, we can unlock the potential for improved crop yield, disease resistance, and nutritional enhancement. With the advancements in genetic engineering techniques, we have the ability to precisely edit plant genomes, allowing us to enhance specific traits and develop plants that are better suited for various agricultural conditions.
CD Biosynsis harnesses the transformative power of the Cell-Free System to catalyze innovation across the biotech landscape. With an unwavering focus on precision, quality, and versatility, we empower researchers and biotech entities to explore new horizons and unlock the full potential of molecular biology. Join us on the journey to redefine the future of biotechnology through our pioneering Cell-Free System Services.
CD Biosynsis specializes in Biosynthesis of gene cluster services, offering cutting-edge solutions for synthetic biology applications. Our comprehensive services encompass gene cluster analysis, design, and optimization to drive innovation in biotechnology.
CD Biosynsis specializes in cutting-edge protein biosynthesis services. Leveraging synthetic biology techniques, we deliver precise and efficient protein synthesis solutions tailored to your unique research and industrial needs.
Our Salmonella Genome Editing Service offers precise and efficient solutions for genetic modifications in Salmonella species, optimizing them for use in research, vaccine development. Utilizing state-of-the-art genome editing technologies such as CRISPR/Cas9, we provide comprehensive support from project design to final validation, ensuring your genome editing goals are achieved with high accuracy and efficiency.
Our Pseudomonas aeruginosa Genome Editing Service offers precise and efficient solutions for genetic modifications in Pseudomonas aeruginosa, optimizing them for use in research, industrial applications, and medical biotechnology. Utilizing state-of-the-art genome editing technologies such as CRISPR/Cas9, TALENs, and recombineering, we provide comprehensive support from project design to final validation, ensuring your genome editing goals are achieved with high accuracy and efficiency.
Our specialized biotechnology services are dedicated to the precise biosynthesis of insulin, exclusively for scientific research purposes. Our commitment is to provide state-of-the-art technical solutions in the realm of insulin production, catering to the exacting needs of researchers and laboratories.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.
